Ng DK, Pierce CB. Kidney disease progression in children and young adults with pediatric CKD: Epidemiologic perspectives and clinical applications. Semin Nephrol 2021; 41:405–415. doi: 10.1016/j.semnephrol.2021.09.002

• PubMed
Ng DK, Pierce CB. Kidney disease progression in children and young adults with pediatric CKD: Epidemiologic perspectives and clinical applications. Semin Nephrol 2021; 41:405–415. doi: 10.1016/j.semnephrol.2021.09.002 )| false
• Search Google Scholar
• Export Citation

Modi ZJ, et al. Inpatient pediatric CKD health care utilization and mortality in the United States. Am J Kidney Dis 2021; 77:500–508. doi: 10.1053/j.ajkd.2020.07.024

• PubMed
Modi ZJ, Inpatient pediatric CKD health care utilization and mortality in the United States. Am J Kidney Dis 2021; 77:500–508. doi: 10.1053/j.ajkd.2020.07.024 )| false
• Search Google Scholar
• Export Citation

Gipson DS, et al. Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis. JAMA Netw Open 2022; 5:e2228701. doi: 10.1001/jamanetworkopen.2022.28701

• PubMed
Gipson DS, Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis. JAMA Netw Open 2022; 5:e2228701. doi: 10.1001/jamanetworkopen.2022.28701 )| false
• Search Google Scholar
• Export Citation

Drube J, et al.; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 2019; 15:577–589. doi: 10.1038/s41581-019-0161-4

• PubMed
Drube J, ; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 2019; 15:577–589. doi: 10.1038/s41581-019-0161-4 )| false
• Search Google Scholar
• Export Citation

Hooper SR, et al. Overview of the findings and advances in the neurocognitive and psychosocial functioning of mild to moderate pediatric CKD: Perspectives from the Chronic Kidney Disease in Children (CKiD) cohort study. Pediatr Nephrol 2022; 37:765–775. doi: 10.1007/s00467-021-05158-w

• PubMed
Hooper SR, Overview of the findings and advances in the neurocognitive and psychosocial functioning of mild to moderate pediatric CKD: Perspectives from the Chronic Kidney Disease in Children (CKiD) cohort study. Pediatr Nephrol 2022; 37:765–775. doi: 10.1007/s00467-021-05158-w )| false
• Search Google Scholar
• Export Citation

Crawford K, et al. Transitioning adolescents to adult nephrology care: A systematic review of the experiences of adolescents, parents, and health professionals. Pediatr Nephrol 2020; 35:555–567. doi: 10.1007/s00467-019-04223-9

• PubMed
Crawford K, Transitioning adolescents to adult nephrology care: A systematic review of the experiences of adolescents, parents, and health professionals. Pediatr Nephrol 2020; 35:555–567. doi: 10.1007/s00467-019-04223-9 )| false
• Search Google Scholar
• Export Citation

Oliverio AL, et al. Validating a computable phenotype for nephrotic syndrome in children and adults using PCORnet data. Kidney360 2021; 2:1979–1986. doi: 10.34067/KID.0002892021

• PubMed
Oliverio AL, Validating a computable phenotype for nephrotic syndrome in children and adults using PCORnet data. Kidney360 2021; 2:1979–1986. doi: 10.34067/KID.0002892021 )| false
• Search Google Scholar
• Export Citation

Harada R, et al. Epidemiology of pediatric chronic kidney disease/kidney failure: Learning from registries and cohort studies. Pediatr Nephrol 2022; 37:1215–1229. doi: 10.1007/s00467-021-05145-1

• PubMed
Harada R, Epidemiology of pediatric chronic kidney disease/kidney failure: Learning from registries and cohort studies. Pediatr Nephrol 2022; 37:1215–1229. doi: 10.1007/s00467-021-05145-1 )| false
• Search Google Scholar
• Export Citation

Gadegbeku CA, et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013; 83:749–756. doi: 10.1038/ki.2012.428.

• PubMed
Gadegbeku CA, Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013; 83:749–756. doi: 10.1038/ki.2012.428. )| false
• Search Google Scholar
• Export Citation

Mariani LH, et al. CureGN study rationale, design, and methods: Establishing a large prospective observational study of glomerular disease. Am J Kidney Dis 2019; 73:218–229. doi: 10.1053/j.ajkd.2018.07.020

• PubMed
Mariani LH, CureGN study rationale, design, and methods: Establishing a large prospective observational study of glomerular disease. Am J Kidney Dis 2019; 73:218–229. doi: 10.1053/j.ajkd.2018.07.020 )| false
• Search Google Scholar
• Export Citation

Milliner DS, et al. End points for clinical trials in primary hyperoxaluria. Clin J Am Soc Nephrol 2020; 15:1056–1065. doi: 10.2215/CJN.13821119

• PubMed
Milliner DS, End points for clinical trials in primary hyperoxaluria. Clin J Am Soc Nephrol 2020; 15:1056–1065. doi: 10.2215/CJN.13821119 )| false
• Search Google Scholar
• Export Citation

Chao YC, et al. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis. Contemp Clin Trials 2020; 92:105989. doi: 10.1016/j.cct.2020.105989

• PubMed
Chao YC, Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis. Contemp Clin Trials 2020; 92:105989. doi: 10.1016/j.cct.2020.105989 )| false
• Search Google Scholar
• Export Citation

Adaptive Platform Trials Coalition. Adaptive platform trials: Definition, design, conduct and reporting considerations. Nat Rev Drug Discov 2019; 18:797–807. doi: 10.1038/s41573-019-0034-3 [Erratum in Nat Rev Drug Discov 2019; 18:808. doi: 10.1038/s41573-019-0045-0].

• PubMed
Adaptive Platform Trials Coalition. Adaptive platform trials: Definition, design, conduct and reporting considerations. Nat Rev Drug Discov 2019; 18:797–807. doi: 10.1038/s41573-019-0034-3 [Erratum in Nat Rev Drug Discov 2019; 18:808. doi: 10.1038/s41573-019-0045-0]. )| false
• Search Google Scholar
• Export Citation

U.S. Food & Drug Administration. Guidance Document. E11A Pediatric Extrapolation. August 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e11a-pediatric-extrapolation

• PubMed
U.S. Food & Drug Administration. Guidance Document. E11A Pediatric Extrapolation. August 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e11a-pediatric-extrapolation )| false
• Search Google Scholar
• Export Citation

Gipson DS, et al. A pediatric gateway initiative for glomerular disease: Introducing PIONEER. Kidney Int 2021; 99:515–518. doi: 10.1016/j.kint.2020.11.013

• PubMed
Gipson DS, A pediatric gateway initiative for glomerular disease: Introducing PIONEER. Kidney Int 2021; 99:515–518. doi: 10.1016/j.kint.2020.11.013 )| false
• Search Google Scholar
• Export Citation